BU – Transcatheter Mitral & Tricuspid Therapies Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an
Innovation starts from the heart. Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. With millions of patients served in over 100 countries, each team makes a
Edwards Lifesciences in Europe seeks an Associate Manager, Therapy Development to lead patient activation, referrer engagement, and pathway optimization. You will collaborate with commercial field teams, develop assets, and drive digital engagement to advance therapy development across